BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18182940)

  • 1. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
    Seifert-Klauss V; Kingwell E; Hitchcock CL; Kalyan S; Prior JC
    Menopause; 2008; 15(1):203; author reply 203-4. PubMed ID: 18182940
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(2):168-82. PubMed ID: 17259911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2010 Mar; 17(2):242-55. PubMed ID: 20154637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progestogen use in peri- and postmenopausal women: September 2003 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2003; 10(6):497-506. PubMed ID: 14627857
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(6 Pt 1):589-600. PubMed ID: 15545786
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2017 hormone therapy position statement of The North American Menopause Society.
    Menopause; 2018 Nov; 25(11):1362-1387. PubMed ID: 30358733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for evidence-based medicine to be integrated into clinical practice: role of the North American Menopause Society.
    Pinkerton JV; Wild RA
    Menopause; 2009; 16(3):438-41. PubMed ID: 19352205
    [No Abstract]   [Full Text] [Related]  

  • 9. [Estrogen progestogen replacement therapy for hyperlipidemia in postmenopausal women].
    Hayakawa A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():701-6. PubMed ID: 11347158
    [No Abstract]   [Full Text] [Related]  

  • 10. Global consensus statement on menopausal hormone therapy.
    de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
    Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on continuous estrogen-progestin replacement therapy.
    Rosenfeld JA
    Am Fam Physician; 1994 Nov; 50(7):1519-23, 1527-8. PubMed ID: 7976988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2017 hormone therapy position statement of The North American Menopause Society.
    The NAMS 2017 Hormone Therapy Position Statement Advisory Panel
    Menopause; 2017 Jul; 24(7):728-753. PubMed ID: 28650869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for hormone treatment of women in the menopausal transition and beyond.
    Naftolin F; Schneider HP; Sturdee DW;
    Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
    [No Abstract]   [Full Text] [Related]  

  • 14. Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society.
    Gambacciani M; Biglia N; Cagnacci A; Caruso S; Cicinelli E; DE Leo V; DI Carlo C; Farris M; Gambera A; Guaschino S; Lanzone A; Paoletti AM; Russo N; Vicariotto F; Villa P; Volpe A;
    Minerva Ginecol; 2018 Feb; 70(1):27-34. PubMed ID: 28975776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy: what we know now.
    Roush K
    Am J Nurs; 2011 Jun; 111(6):38-47; quiz 48-9. PubMed ID: 21613919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EMAS position statement: managing obese postmenopausal women.
    Lambrinoudaki I; Brincat M; Erel CT; Gambacciani M; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2010 Jul; 66(3):323-6. PubMed ID: 20434858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
    Birkhäuser MH; Panay N; Archer DF; Barlow D; Burger H; Gambacciani M; Goldstein S; Pinkerton JA; Sturdee DW
    Climacteric; 2008 Apr; 11(2):108-23. PubMed ID: 18365854
    [No Abstract]   [Full Text] [Related]  

  • 19. The pitfalls of non-evidence-based guidelines.
    Col NF; Duffy C; Cyr MG
    Menopause; 2006; 13(3):334-7. PubMed ID: 16735929
    [No Abstract]   [Full Text] [Related]  

  • 20. Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures.
    Cagnacci A; Zanin R; Cannoletta M; Generali M; Caretto S; Volpe A
    Fertil Steril; 2007 Dec; 88(6):1603-8. PubMed ID: 17481628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.